Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo‐adjuvant chemoradiation

Patient selection for organ sparing treatment after good response to neo‐adjuvant chemoradiation (CRT) for locally advanced rectal cancer is challenging as no optimal restaging modality is available after CRT. In this study, we assessed the value of dynamic contrast enhanced magnetic resonance imaging (DCE‐MRI) for rectal cancer pathological response prediction.

[1]  Osama Mawlawi,et al.  Multimodality imaging: an update on PET/CT technology , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  J. Stoker,et al.  Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. , 2013, Radiology.

[3]  K. Haustermans,et al.  Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study , 2011, Annals of Surgical Oncology.

[4]  Myeong-Jin Kim,et al.  Abstracts of selected papers from the current literature , 2003, Abdominal Imaging.

[5]  Jürgen Griebel,et al.  Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. , 2003, International journal of radiation oncology, biology, physics.

[6]  Philippe Lambin,et al.  Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging. , 2010, International journal of radiation oncology, biology, physics.

[7]  Jeong Min Lee,et al.  Dynamic contrast‐enhanced MRI to evaluate the therapeutic response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer , 2014, Journal of magnetic resonance imaging : JMRI.

[8]  Christian Kremser,et al.  Dynamic contrast-enhanced magnetic resonance imaging: a non-invasive method to evaluate significant differences between malignant and normal tissue. , 2005, European journal of radiology.

[9]  Xiaoguang Sun,et al.  18F‐FDG‐PET evaluation of treatment response to neo‐adjuvant therapy in patients with locally advanced rectal cancer: A meta‐analysis , 2012, International journal of cancer.

[10]  Myeong-Jin Kim,et al.  Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer , 2012, European Radiology.

[11]  Kenya Murase,et al.  Efficient method for calculating kinetic parameters using T1‐weighted dynamic contrast‐enhanced magnetic resonance imaging , 2004, Magnetic resonance in medicine.

[12]  J. Petiot,et al.  Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations , 1994, Cancer.

[13]  A. Padhani,et al.  Non‐invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer , 2001, The British journal of surgery.

[14]  Geerard L Beets,et al.  Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  T. Junginger,et al.  Neoadjuvant Chemoradiation and Local Excision for T2-3 Rectal Cancer , 2008, Annals of Surgical Oncology.

[16]  A. Fichera,et al.  Modern Rectal Cancer Multidisciplinary Treatment: The Role of Radiation and Surgery , 2013, Annals of Surgical Oncology.

[17]  G. Beets,et al.  MRI After Chemoradiotherapy of Rectal Cancer: A Useful Tool to Select Patients for Local Excision , 2010, Diseases of the colon and rectum.

[18]  J. Gama-Rodrigues,et al.  Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy , 2006, Journal of Gastrointestinal Surgery.

[19]  Rainer Fietkau,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[20]  J. Jass,et al.  Reporting colorectal cancer. , 1987, Journal of clinical pathology.

[21]  J P Logue,et al.  Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  A. Padhani,et al.  Tumor response assessments with diffusion and perfusion MRI , 2012, Journal of magnetic resonance imaging : JMRI.

[23]  Maaike R Moman,et al.  Pathologic validation of a model based on diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging for tumor delineation in the prostate peripheral zone. , 2012, International journal of radiation oncology, biology, physics.

[24]  M. Philippens,et al.  Diffusion-weighted MRI in locally advanced rectal cancer , 2013, Strahlentherapie und Onkologie.

[25]  Karin Haustermans,et al.  Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. , 2012, International journal of radiation oncology, biology, physics.

[26]  J. Borrás,et al.  Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  J. Hanley,et al.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.

[28]  Philippe Lambin,et al.  Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer. , 2005, International journal of radiation oncology, biology, physics.

[29]  S. Nougaret,et al.  Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: Initial experience , 2013, Journal of magnetic resonance imaging : JMRI.

[30]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[31]  Uulke A. van der Heide,et al.  Simultaneous multi-modality ROI delineation in clinical practice , 2009, Comput. Methods Programs Biomed..